A Canadian Guideline on the Use of Next-Generation Sequencing in Oncology
Open Access
- 1 April 2019
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 26 (2), 241-254
- https://doi.org/10.3747/co.26.4731
Abstract
Rapid advancements in next-generation sequencing (ngs) technology have created an unprecedented opportunity to decipher the molecular profile of tumours to more effectively prevent, diagnose, and treat cancer. Oncologists now have the option to order molecular tests that can guide treatment decisions. However, to date, most oncologists have received limited training in genomics, and they are now faced with the challenge of understanding how such tests and their interpretation align with patient management. Guidance on how to effectively use ngs technology is therefore needed to aid oncologists in applying the results of genomic tests. The Canadian guideline presented here describes best practices and unmet needs related to ngs-based testing for somatic variants in oncology, including clinical application, assay and sample selection, bioinformatics and interpretation of reports performed by laboratories, patient communication, and clinical trials.Keywords
This publication has 36 references indexed in Scilit:
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 MutationsNew England Journal of Medicine, 2015
- Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing ApproachesClinical Cancer Research, 2015
- Next-generation sequencing to guide cancer therapy.Genome Medicine, 2015
- Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS)Molecular Oncology, 2015
- Neoantigens in cancer immunotherapyScience, 2015
- Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancerScience, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- ALCHEMIST: Bringing genomic discovery and targeted therapies to early‐stage lung cancerClinical Pharmacology & Therapeutics, 2015
- FORGE Canada Consortium: Outcomes of a 2-Year National Rare-Disease Gene-Discovery ProjectAmerican Journal of Human Genetics, 2014
- What is next generation sequencing?Archives of Disease in Childhood: Education & Practice, 2013